Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Knight Therapeutics Inc T.GUD

Alternate Symbol(s):  KHTRF

Knight Therapeutics Inc. is a specialty pharmaceutical company. The Company’s principal business activity is developing, acquiring, in-licensing, out-licensing, manufacturing, marketing and distributing pharmaceutical products in Canada, Latin America and select international markets. It finances other life sciences companies and secures product distribution rights for Canada and select international markets. The Company invests in life sciences venture capital funds whereby the Company may receive preferential access to healthcare products for Canada and select international markets. It develops pharmaceutical products, including those to treat neglected tropical and rare pediatric diseases. The portfolio consists of pharmaceutical products with molecules and includes both in-licensed products such as Lenvima, Cresemba, Halaven, Trelstar, Akynzeo, Ambisome, Minjuvi, Imvexxy as well as products owned by Knight such as Exelon and Impavido.


TSX:GUD - Post by User

Comment by MrMugsyon Feb 17, 2022 4:07pm
85 Views
Post# 34439494

RE:RE:RE:RE:RE:Bring back Beaudet (Part II)

RE:RE:RE:RE:RE:Bring back Beaudet (Part II)
PitchinPennies wrote: Let's not overlook that Medison set up shop independently in Canada after the falling out, and currently functions as a competitor-of-a-sort to Knight. That's got to be rough. Kind of like having your ex-wife buying the house across the street and using it to hold noisy raves that you are never invited to -- to offer an analogy that Chianchin will understand.


ya - don't think anyone is afraid of Medison setting up shop in Canada.
I've been trying to follow developments but It's been real slow - go figure.
I don't think Meir was able to market his name to put $600M in the bank in Canada.
Nor do I think he sold a Priortiy Review Voucher for $120M USD.
I don't think he's competing in Mexico or South America either.
But I will tell you that it took Meir his first 10 years to get to $50M in annual sales.

I don't think he's going to be any kind of competition ... certainly not as we ramp up growth !!!

: )
<< Previous
Bullboard Posts
Next >>